Status:

UNKNOWN

Comparing of the Pharmacokinetics, Immunogenicity and Safety of MV088 and Prolia® in Healthy Adults.

Lead Sponsor:

Kunming Pharmaceuticals, Inc.

Conditions:

Healthy

Eligibility:

MALE

18-65 years

Phase:

PHASE1

Brief Summary

A Randomized, Double-blind and Parallel Group Study to Compare the Pharmacokinetics, Immunogenicity and Safety of MV088 and Prolia® in Healthy Adults.

Detailed Description

This is a phase I, double center, randomized, double-blind, single dose and parallel group clinical trial . The primary objective is to assess the pharmacokinetic similarity of MV088 and Prolia® in he...

Eligibility Criteria

Inclusion

  • Aged ≥18 years or ≤65 years, male(including the boundary value).
  • The body weight is within the range of 50\~70kg (including the boundary value) and the body mass index(BMI) is within the range of 19.0\~26.0kg/m2 (including the boundary value).
  • Sign the informed consent form and fully understand the test content, process and possible adverse reactions, and be able to complete the study according to the test plan requirements.
  • The volunteers are able to communicate well with the researchers, understand and comply with the requirements of the study, and are expected to participate in all follow-up visits (no long-term plans to leave the study site).

Exclusion

  • Have participated in any drug or medical device trials or are participating in other clinical trials within 3 months prior to first administration.
  • Occurred or suffering from osteomyelitis or ONJ (mandibular necrosis) previously.
  • The dental or jaw disease that is active, requiring oral surgery; or planned for invasive dental surgery during the study; or dental or oral surgery wounds have not healed.
  • Occurred or suffering hypocalcemia.
  • Have taken any medicine (including Chinese herbal medicine) within 14 days before the first administration.

Key Trial Info

Start Date :

February 22 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 18 2021

Estimated Enrollment :

144 Patients enrolled

Trial Details

Trial ID

NCT04673799

Start Date

February 22 2021

End Date

October 18 2021

Last Update

December 17 2020

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Comparing of the Pharmacokinetics, Immunogenicity and Safety of MV088 and Prolia® in Healthy Adults. | DecenTrialz